Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on US Healthcare Journal.
Press releases published on March 7, 2025
Testosterone Booster Market Poised for USD 8.3B Valuation by 2033 at 5.8% CAGR
EIN Presswire
·
March 7, 2025
Testosterone Booster Market was valued at USD 4.8 Billion in 2023, and is expected to reach USD 8.3 Billion in 2033, at a CAGR of 5.8% NEW YORK, NY, UNITED STATES, March 6, 2025 /EINPresswire.com/ -- Testosterone Booster Market Set for 5.8% CAGR …
Stretch Marks Treatment Market Set for 8.0% CAGR Growth, Surpassing USD 6.1 Billion
EIN Presswire
·
March 7, 2025
Stretch Marks Treatment Market was valued at USD 2.9 billion in 2023. It is expected to reach USD 6.1 billion by 2033, with a CAGR of 8.0% NEW YORK, NY, UNITED STATES, March 6, 2025 /EINPresswire.com/ -- The Stretch Marks Treatment Market was valued at …
Generic Drug Market Size Will Achieve USD 795.68 Billion By 2032 – Data Analysis by Emergen Research
EIN Presswire
·
March 7, 2025
The global Generic Drug Market size was USD 360.84 Billion in 2022 and is expected to register a rapid revenue CAGR of 8.4% VANCOUVER, BC, CANADA, March 7, 2025 /EINPresswire.com/ -- The global Generic Drug Market size was USD 360.84 Billion in 2022 and …
Introducing the Online Museum of African Americans: A Virtual Gateway to History and Legacy
EIN Presswire
·
March 7, 2025
A New Museum for a New Era: The Online Museum of African Americans NEW YORK, NY, UNITED STATES, March 7, 2025 /EINPresswire.com/ -- A groundbreaking transformation in historical preservation is here. The Museum of the History of Black Doctors has …
Nanobles Corp & GCRC Announce Investment and Partnership Opportunities to Revolutionize Health & Wellness
EIN Presswire
·
March 7, 2025
"I think we should all invest in our future, in the future of mankind - the timing has never been better than now to start a wellness revolution" -Mike Robinson SANTA BARBARA, CA, UNITED STATES, March 6, 2025 /EINPresswire.com/ -- Nanobles Corporation, …
Artax Biopharma Presents New Preclinical Data on Nck Modulators at 2025 AAD Annual Meeting
GlobeNewswire
·
March 7, 2025
Nck modulator reduced evidence of inflammation in an animal model of dermal irritation Compelling preclinical data support continued development of Nck modulators in atopic dermatitis CAMBRIDGE, Mass., March 07, 2025 (GLOBE NEWSWIRE) -- Artax Biopharma, …
Herbal Medicine Market Size Will Achieve USD 429.25 Billion By 2032 – Data Analysis by Emergen Research
EIN Presswire
·
March 7, 2025
The global Herbal Medicine Market size was USD 201.80 billion in 2022 and is expected to register a revenue CAGR of 7.9% VANCOUVER, BC, CANADA, March 7, 2025 /EINPresswire.com/ -- The global Herbal Medicine Market size was USD 201.80 billion in 2022 and …
LOXIM Launches Cutting-Edge Solution for Vibrating Mesh Nebulizer with Chip (LX8201-0B)
EIN Presswire
·
March 7, 2025
SHENZHEN, CHINA, March 7, 2025 /EINPresswire.com/ -- Recently Shenzhen Loxim Technologies Co., Ltd. (LOXIM) has unveiled its latest innovation, the LX8201-0B chip, a dedicated drive solution for vibrating mesh nebulizer. It brings breakthrough to …
Capricor Therapeutics to Present at Leerink’s Global Healthcare Conference 2025
GlobeNewswire
·
March 7, 2025
SAN DIEGO, March 07, 2025 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, today announced that Capricor management will …
Revenue Cycle Optimizations Among Nextech Enhancements on Display at AAD 2025
GlobeNewswire
·
March 7, 2025
TAMPA, Fla., March 07, 2025 (GLOBE NEWSWIRE) -- Nextech, the leader in healthcare technology and practice management solutions for specialty providers, today announced it will preview the latest enhancements to its 2025 Best in KLAS®-winning technology …
PDS Biotech Initiates VERSATILE-003 Phase 3 Clinical Trial Evaluating Versamune® HPV in HPV16-Positive Head and Neck Cancer
GlobeNewswire
·
March 7, 2025
PRINCETON, N.J., March 07, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today announced …
Evident Launches “EviSmart Downloader” to Streamline File Intake Across Multiple Scanners and Portals
EIN Presswire
·
March 7, 2025
VANCOUVER, BRITISH COLUMBIA, CANADA, March 6, 2025 /EINPresswire.com/ -- Evident, a pioneer in digital dentistry solutions, today announced EviSmart Downloader, a new product that automatically retrieves and imports files from various intraoral scanners …
ICU Medical to Participate at the KeyBanc Healthcare Forum
GlobeNewswire
·
March 7, 2025
SAN CLEMENTE, Calif., March 07, 2025 (GLOBE NEWSWIRE) -- ICU Medical (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will participate in a fireside chat at the KeyBanc …
Oruka Therapeutics Announces Preclinical Data for ORKA-002 at the 2025 American Academy of Dermatology Annual Meeting
GlobeNewswire
·
March 7, 2025
Half-life in non-human primates (NHP) of more than 30 days, over three times longer than bimekizumab and expected to support a dose interval of two to three times per year Equivalent potency to bimekizumab with similar binding affinity and epitope …
Lexicon Pharmaceuticals to Present at the Leerink Partners Global Healthcare Conference 2025
GlobeNewswire
·
March 7, 2025
THE WOODLANDS, Texas, March 07, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Company management will participate in a fireside chat at the Leerink Partners Global Healthcare Conference 2025 in Miami on …
Achieve Life Sciences to Present at the Barclays 27th Annual Global Healthcare Conference
GlobeNewswire
·
March 7, 2025
SEATTLE and VANCOUVER, British Columbia, March 07, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of …
ProPhase Labs to Present at the Investor Summit Virtual on March 11
GlobeNewswire
·
March 7, 2025
GARDEN CITY, NY, March 07, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next-generation biotech, genomics, and consumer products company, today announced that Ted Karkus, CEO, will be presenting at this year’ …
Arcutis to Highlight Data from Phase 3 Trials for Scalp and Body Psoriasis and Atopic Dermatitis at the 83rd American Academy of Dermatology Meeting
GlobeNewswire
·
March 7, 2025
Data demonstrated favorable safety and local tolerability of ZORYVE® (roflumilast) cream 0.15% in adults and children with atopic dermatitis (AD) with prior inadequate response, intolerance, and contraindications to topical treatments New patient reported …
AskBio Advances Gene Therapy Clinical Trial for Limb-Girdle Muscular Dystrophy Type 2I/R9 with Dosing of First Participant in Second Cohort
GlobeNewswire
·
March 7, 2025
Research Triangle Park, N.C., March 07, 2025 (GLOBE NEWSWIRE) -- Data Safety Monitoring Board (DSMB) recommendation to initiate second cohort follows review of Phase 1/Phase 2 LION-CS101 trial safety data for AB-1003 Second cohort enrollment is ongoing …
Lifeward Ltd. Reports Fourth Quarter and Full Year 2024 Financial Results
GlobeNewswire
·
March 7, 2025
Record quarterly and annual revenue of $7.5M and $25.7M, respectively Continued strong growth in U.S. pipeline of ReWalk opportunities with over 110 qualified leads in process Strategic shift towards profitability: 2025 Sustainable Growth Plan focuses on …